Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Jesse Ledger, Chief Executive Officer, Nuvo Pharmaceuticals Inc.
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Nuvo Pharmaceuticals Inc.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Understanding the Four Pillars of Capital: Insights from Caspar Helmore | Caspar Helmore, Partner - Client Management
00:10:00
BIO-key CEO Michael DePasquale Highlights Major Contract Wins and Cybersecurity Solutions | Michael DePasquale, CEO, BIO-key International Inc.
00:10:00
Interview with Michael Riley, CEO of Group Ten Metals: Exploring Opportunities in the Stillwater Complex
00:10:00
Abhishek Bansal Discusses Strategy, Innovation, and the Future of Abans Holdings | Abhishek Bansal , CEO , Abans Holdings Ltd.
00:10:00
Regulus Resources: Unveiling Potential in Peru's Copper-Gold Landscape
00:10:00
American West Metals Ltd CEO Dave O'Neill Discusses Major Copper Exploration Efforts at Storm Project | Dave O'Neill, CEO, American West Metals Ltd.
00:00:00
Inorganic Nitrate Benefits and Tolerability of Exercise Training - Dr. Barry Borlaug, a Cardiologist and Heart Failure Specialist at Mayo Clinic
00:10:00
What founders need to know about responsible AI|Nikhil Sachdev,Managing Director,Insight Partners
00:10:00
Dato' Lee's Insider Perspectives: Unveiling the Visionary Mind behind Matrix Concept Holdings Berhad
00:10:00
Lithium Exploration Campaign Nears Completion with Key Updates Expected
00:10:00
Pegasystems Inc. founder and CEO, Alan Trefler, discussed company insights with Dave Vellante, host of theCUBE, SiliconANGLE Media.|Alan Trefler is the Founder and CEO of Pegasystems Inc.,
00:00:00
Ed Gudaitis, President and CEO, Acerus Pharmaceuticals Corporation